Litcius/Paper detail

Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma

Giuseppe Lamberti, Elisa Andrini, Monia Sisi, Alessandro Rizzo, Claudia Parisi, Alessandro Di Federico, Francesco Gelsomino, Andrea Ardizzoni

2020Critical Reviews in Oncology/Hematology136 citationsDOI

Topics & Concepts

KRASROS1Lung cancerMedicineTargeted therapyAdenocarcinomaCrizotinibCancerOncologyCancer researchInternal medicineColorectal cancerMalignant pleural effusionLung Cancer Treatments and MutationsCancer therapeutics and mechanismsLung Cancer Research Studies
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma | Litcius